Psychomotor symptoms and treatment outcomes of ziprasidone monotherapy in patients with major depressive disorder: a 12-week, randomized, double-blind, placebo-controlled,...

Jeon, Hong Jin; Fava, Maurizio; Mischoulon, David; More

International Clinical Psychopharmacology . 29(6):332-338, November 2014.

Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort...

Bitran, Stella; Farabaugh, Amy H.; Ameral, Victoria E.; More

International Clinical Psychopharmacology . 26(4):206-212, July 2011.

Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome

Farabaugh, Amy H.; Bitran, Stella; Witte, Janet; More

International Clinical Psychopharmacology . 25(4):214-217, July 2010.

Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study

Papakostas, George I.; Clain, Alisabet; Ameral, Victoria E.; More

International Clinical Psychopharmacology . 25(1):17-21, January 2010.

Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis...

Papakostas, George I.; Cooper-Kazaz, Rena; Appelhof, Bente C.; More

International Clinical Psychopharmacology . 24(1):19-25, January 2009.

A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsed

Papakostas, George I.; Petersen, Timothy; Worthington, John J.; More

International Clinical Psychopharmacology . 18(5):293-296, September 2003.